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The structure of rat cathepsin L gene has been determined. The gene spans 8.5 kilobase pairs comprising 8 exons, and has an intron located near 
the active site cysteine residue. The gene structure does not correspond well to the functional units of the proteinase. These characteristics are 
found to be in common with the cysteine proteinase gene family. In the S-upstream region, one CAAT-box and four SP-1 binding sites, together 
with two AP-2 binding sites and CRE, but no typical TATA-box are found. Further, SP-1 and AP-2 binding sites and an octamer motif are also 
found in the 1st intron, suggesting acomplex regulatory mechanism for the expression of the cathepsin L gene. 
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1. INTRODUCTION 2. MATERIALS AND METHODS 
Cathepsin L is a typical cysteine proteinase which, 
together with cathepsins B and H, belongs to the papain 
superfamily [ 11. These proteinases play a major role in 
intracellular proteolysis [2]. In addition, extracellular 
functions for cathepsins B and L have been reported; 
for example, cathepsins B and L have been implicated 
in tumor metastasis [3,4], and cathepsin L in em- 
physema [5]. Recently, a major protein excreted from 
ras-transformed NIH3T3 cells (MEP) was identified as 
mouse cathepsin L [6]. Secretion of cathepsin L from 
NIH3T3 cells is also observed upon treatment of cells 
with a tumor promoter, TPA and PDGF [7,8]. These 
factors affect the transcription level of the cathepsin L 
gene but not of the cathepsin H gene even though 
cathepsins L and H show very high amino acid sequence 
homology [l] and are presumably derived from a com- 
mon ancestral gene. To elucidate the functional diversi- 
ty and regulatory mechanism for gene expression, we 
analyzed the structure of the cathepsin L gene. 
In this paper, we reported the structure of the rat 
cathepsin L gene and the nucleotide sequence of the 
5 ‘-upstream region and the 1st intron which probably 
regulates cathepsin L gene transcription. 
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2.1. Materials 
Materials used in this work were obtained from the following 
sources: restriction enzymes from Takara Shuzo, Toyobo and New 
England Biolab.; [a-“P]dCTP and [y-“P]ATP from Amersham and 
ICN; multi-prime labeling kit and nylon membrane Hybond N from 
Amersham; T7 DNA polymerase sequencing kit from Toyobo; other 
enzymes from Takara Shuzo. 
2.2. Methods 
BamHI fragment of cDNA for rat cathepsin L [I] (from - 57 to 
1088) was labeled with [cu-32P]dCTP by a multi-prime labeling kit and 
used as a probe. All procedures from screening to sequencing were 
carried out as previously described [9]. Si mapping analysis was car- 
ried out as described [lo]; i.e. hybridization at 65°C overnight and 
digestion with 1000 U/ml of Si nuclease at 30°C for 30 min. Nu- 
cleotide sequence homology was sought in the Genebank. 
3. RESULTS AND DISCUSSION 
3.1. Isolation and characterization of rat cathepsin L 
gene 
From the rat genomic library (3.2 x lo5 independent 
clones), 4 positive clones were isolated. Judging from 
restriction mapping, these inserts were derived from a 
single gene and overlapped one another. Genomic 
Southern hybridization analyses show that the cathep- 
sin L gene is a single copy (data not shown), and that 
hGL1 and hGL6, spanning in total 18.5 kbp, encom- 
pass the rat cathepsin L gene (fig.1). 
Nucleotide sequence analyses of these clones and nu- 
cleotide sequence comparison between the gene and 
cDNA show that the rat cathepsin L gene spans 8.5 kbp 
and comprises 8 exons. The pre- and pro-peptide 
regions are encoded by exon 2 and exons 2-4, respec- 
tively. Exons 4-8 encode the mature enzyme region and 
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Fig.1. Restriction maps and schematic structure of the rat cathepsin L gene. hNl0 is a full length cDNA clone for rat cathepsin L. Its schematic 
structure is shown at the top. Solid bars indicate 5’- and 3’-noncoding regions. The coding regions for the pro-peptide region and the mature en- 
zyme region are stippled and horizontally shaded, respectively. The open area indicates the pre-peptide region. hGL1 and AGL6 span 18.5 kbp. 
Exons are shown by numbered filled areas. Arrows indicate the directions and lengths of sequencing. Restriction enzymes: hruII (P), Xmnl (X), 
SmaI (S), BumHI (B), EcoRV (E), NcoI (N), HincII (H). 
exon 1 codes only the 5 ‘-upstream region (table 1 and 
fig. 1). The rat cathepsin L gene structure does not cor- 
respond to its functional units. An intron insertion is 
found near the active site Cys residue (fig.2). These 
characteristics are found in common with gene struc- 
tures of cysteine proteinases [9]. Each exon spans 
101-225 bp in length, except for exon 8 (397 bp), and 
contains 43.2-51.2% GC, except for exon 1 (61.0%) 
and exon 8 (38.3%). All boundary sequences are consis- 
tent with the GT-AG rule [l l] (data not shown). 
The nucleotide sequence of the rat cathepsin L gene 
differs from that of the cDNA spanning ca. 1.4 kbp in 
5 positions (table 1). Two alternations are located in the 
3 ‘-noncoding region. The adenine-12 in the cDNA se- 
quence which is replaced by guanine in the gene se- 
quence is a silent change. The cytosine in the gene se- 
quence corresponding to guanine-93 in the cDNA se- 
quence causes an amino acid change from Gln-( - 16) to 
His. The guanine in the gene sequence corresponding to 
cytosine-712 in the cDNA sequence causes an amino 
acid change from Pro-125 to Ala. The amino acid 
residue for cytosine-712 determined at the protein level 
[12] is Ala rather than Pro, indicating that cytosine-712 
has arisen from a mismatch during cDNA synthesis. 
The other cases are probably due to sequence polymor- 
phism. 
The gene structures of rat cathepsins H and L are not 
so similar in spite of their common ancestry [I]. 
Numbers and positions of introns are distinct (fig.2). 
Only two introns, including one immediately before the 
active site Cys residue, are located in the same posi- 
tions. In the case of the serine proteinase superfamily, 
introns conserved at the amino acid sequence level are 
located immediately after the active site His residue and 
before the active site Ser residue [13]. Other introns are 
72 
probably located in the surface loop regions of the 
three-dimensional structure [ 141 and are not conserved. 
In the cysteine proteinase superfamily, a similar situa- 
tion is not observed. No intron position was found near 
the cleavage site where processing from a single-chain 
form to a two-chain form occurs, a region that is prob- 
ably a loop out in the three-dimensional structure. Most 
Table 1 
Summary of the rat cathepsin L gene structure and differences in 
nucleotide sequences between the gene and its cDNA 
Exon Nucleotide (bp) W-content Difference 
no. of cDNA PO) Gene cDNA 
1 -112--12 (101) 61.0 
2 -11- 126 (137) 49.6 
7 785- 902 
8 903-1299 
127- 249 
250- 396 
397- 621 
622- 784 
(123) 51.2 
(147) 49.0 
(225) 48.0 
(163) 48.5 
(118) 43.2 
(397) 38.3 
TTG TTA [12] 
(Leu) (Leu) 
CAC CAG [93] 
(His) (Gln) 
GCT CCT 17121 
(Ala) (Pro) 
TTA TGA [1027] 
(3 ‘-noncoding) 
TGT TTT 112681 
(3 ‘-noncoding) 
Exons are numbered from 5 ’ to 3 ’ in the direction of transcription. 
Nucleotide numbering of the cDNA starts at the initiation codon 
ATG. Negative numbers indicate 5’noncoding regions. the 5’-end of 
exon 1 represents amajor protection site in St mapping analysis. The 
3 ‘-end of exon 8 represents the poly(A)+ addition site. Nucleotide se- 
quences that differ between the gene and its cDNA are underlined. 
Numbers in brackets show the nucleotide number in the cDNA se- 
quence. Amino acids in parentheses below the nucleotide sequences 
are deduced from the nucleotide sequence 
Volume 259, number 1 FEBS LETTERS December 1989 
TTCTTCAGCAGGCCTTTTTTCCTAAACTATTTGACAGGACCi 
AGGCACCAGCCTGGCGCCGACCCTCCTCCAAAAGGAAGCTCAGCCTGGCCGCAGCGGCT~ 
AP-2 AP-2 
GAACCACAGGACnGGTTACGACCCGGCGGCGTCACGCGACCGGAGTCCCGCAAGCT~ 
CRE SP-1 
CCCGAGGCAGGCACAGCCAATGACTGGGGCGGGGGCGGGCCTTGCCGGGGCCGCAGCCTG 
SP-1 SP-1 SP-1 
AGAGCCT~TAAAGCCGGAGCCCGCTCTGCTTTTCCAGAPTCTCGGACCTCGGCGACCTCC 
GGGGATCCGAGTTTGCAGACTACGTGTGTGCGCAGCTAGCCACCTCAGG~GAGTGACCC~ 
EXON-1 
CTCCCCGCCCCCCGAGGGTTTAAACGCTTCGCAAGCAAGGATAGATAGG~GAATGTAGA~ 
SP-1 
CGTGGGATCCACAGCATTTGCAACCCGAACTGCGGACCCCCGGCTGGCCAGGATCTCCAG 
OCTA 
GAGGTGTCCCTTGGCTTTCCCGAAGTGATAGGCCCTTGTT 
ACGGGGCCCAGGGCTCCCT~TGCCGCCAT;IACACTCGT~~GCGGTGGCT~CGACGGCTG~ 
SP-1 
GCAGACGCC;rAT CCCCCGG;;CGGGCCCAGCTTGGCTCCTA-----( 500 bp.)----- 
AP-2 Sp-1 
. 
GATCCTCAATTCCTCTTCTTTTTCCTTCCCCAGGTGTTTGAACCATGACCCCTTTGCTCC 
. 
TCCTGGCTGTCCTCTGCTTGGGAACAGCCTTAGCCACTCCAAAATTTGATCAAACGTTTA 
EXON-2 . . . . 
ATGCACACTGGCACCAGTGGAAGTCCACACACAGAAGACTGTATGGCACGGTTTGTAG'~~ 
B 
Rat cathepsin L gene GGGGCGGGGGCGGGCCTTGCCGGGGCC 
***************** ** ** *** 
Human c-abl gene GGGGCGGGGGCGGGCCTGGCGGGCGCC 
150 160 170 
Fig.3. (A) Nucleotide sequence around the 1st exon. Thick lines below the nucleotide sequence indicate the cDNA sequences, namely, exon 1 and 
exon 2. Double thin underlining shows the CUT-box. Single thin underlining indicates promoter-enhancer lements; SP-1, activator protein 2 
binding sequence (AP-2), CAMP regulatory element (CRE) and octamer motif (OCTA). The arrowhead indicates a major protection position in 
Sr mapping analysis. (B) Comparison of nucleotide sequences between an SP-1 binding sites cluster region (59-85 bp upstream from 5’-end of 
cDNA) in the rat cathepsin L gene and the c-abl gene [21]. Asterisks indicate identical nucleotides. 
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intron positions are located near Cys residues which are 
important in supposing three-dimensional structure 
(fig.2). 
3.2. Nucleotide sequence of 5 ‘-upstream and 1st intron 
The nucleotide sequence of the rat cathepsin L gene 
around exon 1 is shown in fig.3A. St mapping analysis 
(data not shown) revealed that the major transcrip- 
tional initiation site was at T, 42 b upstream of the end 
of the cDNA. In the 5’upstream region, one CAAT- 
box and four SP-1 binding sites were found, but no 
typical TATA-box existed [ 151. A typical TATA-box is 
also lacking in the 5 ‘-upstream region of genes for lyso- 
somal enzymes such as lysosomal human cy- 
galactosidase and human fl-hexosaminidase cy- and p- 
chains [16-191, although the CAAT-box and SP-1 bind- 
ing sites exist. These characteristics may be common 
among the 5 ‘-upstream regions of Iysosomal enzyme 
genes. In addition three SP-1 binding sites were found 
in the 1st intron. Since introns affect the transcriptional 
level in some cases 1201, these SP-1 binding sites may 
also affect the transcriptional evel of rat cathepsin L. 
A search for nucleotide sequence homology in the 
Genebank shows that a region 59-85 bp upstream from 
the 5 ‘-end of cDNA, where three SP-1 binding sites are 
clustered, is homologous to the promoter region of the 
ubiquitously expressed c-abl gene (fig.3B) [21]. This 
fact suggests that this region may be the basic promoter 
region of cathepsin L. 
Various enhancer elements, i.e. AP-2, SP-1, CRE 
and an octamer motif [22,23], found in the 5 ‘-upstream 
region and in the 1st intron may also regulate transcrip- 
tion of the cathepsin L gene. Ras-transformed NIH3T3 
and normal NIH3T3 cells secrete cathepsin L as a major 
excreted protein (MEP) upon treatment with TPA and 
PDGF [6-81. Troen et al. isolated the MEP gene and 
demonstrated that this gene spans more than 8 kbp and 
comprises more than 6 exons, judging from genomic 
Southern hybridization analysis [24]. These results are 
preliminary, but consistent with our present results. 
Nevertheless, the transcription level of cathepsin L in 
African green monkey kidney CV-I cells and human 
epidermoid carcinoma A43 1 cells transfected with 
cathepsin L gene is not affected by treatment with TPA. 
The results suggest hat the effect of TPA is cell-type- 
specific. AP-2, a tissue specific trans-acting factor may 
be responsible for tissue-specific induction of cathepsin 
L by TPA. In addition, the presence of CRE, a ubi- 
quitous enhancer, suggests that the gene expression of 
cathepsin L may be affected by intracellular CAMP 
level. Transcriptional regulation of the cathepsin L gene 
is quite complex and apparently requires further precise 
analysis. 
Knowledge of the cathepsin L gene will provide a clue 
to understanding the molecular evolution and func- 
tional diversity among cysteine proteinases and the 
mechanism for transcriptional regulation. 
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